https://www.selleckchem.com/pr....oducts/5-cholesten-3
th naldemedine 0.2 mg was generally well tolerated and effective in patients aged ≥ 65 years with chronic non-cancer pain. Safety and efficacy results were consistent with the overall patient population. CLINICALTRIALS. GOV REGISTRATION NCT01965158, NCT01993940, NCT01965652.PURPOSE To analyze the factorial structure of the eight short versions of the Body Shape Questionnaire (BSQ) and analyze the factorial invariance of the best model, its convergent validity and its internal consistency in three age groups of Mexican
Like
Comment
Share
